JNL/Loomis Sayles Global Growth Fund

JNL Series Trust

Actively managed global equity fund
$2.01B NAV
44 positions · as of 2026-06-30 · filed 2026-08-26

Fund classification

Classified from what the fund holds · as of 2026 Q2

JNL/Loomis Sayles Global Growth Fund is an actively managed global equity fund.

Asset class
Equity
Region
Global
Management
Actively managed
Fund type
Open-end fund
Features
Non-diversified

Fund profile

As filed in the prospectus · 2026 Q2

The investment objective of the Fund is long-term growth of capital.

Strategy · summarised

The fund invests globally across at least three countries including the U.S., with at least 30% of assets in non-U.S. securities selected by sub-adviser Loomis, Sayles & Company for sustainable competitive advantages, structural growth drivers, and attractive cash flow returns on invested capital, typically at a discount to estimated intrinsic value. The fund may invest up to 30% in emerging markets securities. As a non-diversified fund, it may concentrate more of its assets in fewer issuers than diversified mutual funds. The fund does not normally hedge currency risk, which may cause losses that would not have occurred had the risk been hedged.

Expenses
0.70% 1.00%across 2 share classes
Share classExpense ratioAs of
C0002026430.70%2025 Q2
C0002026441.00%2025 Q2

Portfolio turnover 14.00% · as of 2026 Q2

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

99.88%
of net assets
Stocks97.35%
Cash & short-term2.52%

Derivatives are shown at market value, not notional exposure.

Sector allocation

The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2

100%
of net assets
International27.3%
Communication Services19.7%
Consumer Discretionary19.5%
Information Technology14.7%
4 smaller18.8%

Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 1 new3 exited

New: Barclays Capital Inc.

Exited: CRISPR Therapeutics AG, BABA, QCOM

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

1-year
+13.05%
3-year
+60.91%
5-year
+37.68%
Volatility
17.65%
Worst 3-yr fall
-16.17%
Cumulative return· Jul 2023 – Apr 2026

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
Alphabet Inc.GOOGL9.34%$187.38M
Meta Platforms, Inc.META6.66%$133.60M
Amazon.com, Inc.AMZN6.58%$132.04M
Tesla Inc.TSLA6.55%$131.39M
MercadoLibre, Inc.MELI5.11%$102.47M
Shopify Inc.SHOP4.41%$88.35M
Novartis AG3.97%$79.66M
Arm Holdings PLCARM3.91%$78.41M
The Boeing CompanyBA3.76%$75.38M
Netflix, Inc.NFLX3.70%$74.22M
Showing 10 of 44Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

Top 10 positions are 54.00% of net assets, top 25 87.59%, across 44 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free